Skip to main content
Premium Trial:

Request an Annual Quote

Idaho Technologies, Bio-Rad Reach Licensing Agreement

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Idaho Technologies and Bio-Rad Laboratories announced after the close of the market on Tuesday a licensing agreement covering SYBR Green in PCR reactions and high-resolution melting.

Financial and other terms of the deal were not disclosed.

SYBR Green is a product of Life Technologies' Invitrogen business, but Idaho Technologies holds the patent for its use in PCR research, an Idaho Technology official said. During the summer, the company licensed reagents and methods covering the SYBR technology to E.I du Pont de Nemours, commonly known as DuPont.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more